SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-204956
Filing Date
2023-08-07
Accepted
2023-08-07 16:05:37
Documents
12
Period of Report
2023-08-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d533741d8k.htm   iXBRL 8-K 26623
  Complete submission text file 0001193125-23-204956.txt   148989

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnov-20230804.xsd EX-101.SCH 2859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20230804_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20230804_pre.xml EX-101.PRE 11267
6 EXTRACTED XBRL INSTANCE DOCUMENT d533741d8k_htm.xml XML 3448
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 231147580
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences